Nektar Likely To Drift And Wobble Ahead Of Key Phase II Data In 2025 (NKTR)Nektar Likely To Drift And Wobble Ahead Of Key Phase II Data In 2025 (NKTR)
tylim/iStock via Getty Images Failure is the base-case assumption for biotechs, as fewer than 10% of drugs that go into[...]